SpineGuard has obtained a new patent in the United States, after obtaining in China, Japan, Mexico, France, Israel, Russia and Singapore. This patent presents certain characteristics of the DSG technology allowing the optimization of its implementation in real time.
Since its creation, SpineGuard has developed and maintained a significant intellectual property portfolio reaching to date 15 families totaling 78 patents or deposits, as well as 3 brands, in the main global geographic areas including Europe, the United States and China.
SpineGuard is focusing on the following priorities that it intends to achieve by investing selectively while remaining close to balance: increasing commercial activity with the launch of the DSG-Connect interface; implement DSG digital technology in surgical robotics through the deployment of artificial intelligence algorithms, scientific demonstrations and new patents; intensify the co-development of a new generation of dental instruments integrating DSG technology in collaboration with the company ConfiDent ABC; and assert its technological shift and lead to the conclusion of new strategic partnerships, in particular for the robotics application of DSG.
–
